Disclosures: Callaghan is employed by Olympus.
August 14, 2020
1 min read

Olympus acquires Arc Medical Design, Endocuff devices

Disclosures: Callaghan is employed by Olympus.
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Olympus announced a deal to acquire Arc Medical Design, creator of the Endocuff devices designed to improve adenoma detection during colonoscopy, according to a company press release.

Olympus already holds the rights to the Endocuff Vision device, and now will acquire the rights to other devices, including Endocuff Glide and Enterocuff

“It is a great pleasure to announce our acquisition of Arc Medical Design,” Mike Callaghan, vice president and general manager of Global GI EndoTherapy business unit at Olympus, said in the release. “Endocuff Vision has been a pivotal tool in our EndoTherapy portfolio, and we are delighted to expand our product portfolio to include the entire ENDOCUFF family.”

The Endocuff Vision attaches to the distal end of a colonoscope and helps flatten colonic folds and improve mucosal visualization during colonoscopy. Previous studies have shown that the device decreases withdrawal time without sacrificing adenoma detection.

“We are excited about the acquisition of Arc Medical Design as it expands our expertise in innovative medical technology, strengthens our global leadership in endoscopy and reinforces the commitment to our purpose of making people’s lives healthier, safer and more fulfilling,” Callaghan said in the release.